Advisor Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$65K Sell
3,672
-136
-4% -$2.35K ﹤0.01% 3235
2019
Q3
$57K Sell
3,808
-121
-3% -$1.99K ﹤0.01% 3292
2019
Q2
$68K Buy
3,929
+34
+0.9% +$549 ﹤0.01% 3149
2019
Q1
$62K Sell
3,895
-478
-11% -$7.75K ﹤0.01% 3233
2018
Q4
$64K Sell
4,373
-111
-2% -$1.77K ﹤0.01% 3007
2018
Q3
$82K Buy
4,484
+1,455
+48% +$25.5K ﹤0.01% 2895
2018
Q2
$52K Sell
3,029
-152
-5% -$2.87K ﹤0.01% 3074
2018
Q1
$63K Buy
3,181
+751
+31% +$14.5K ﹤0.01% 2893
2017
Q4
$49K Buy
2,430
+700
+40% +$12.9K ﹤0.01% 3095
2017
Q3
$29K Buy
1,730
+57
+3% +$772 ﹤0.01% 3339
2017
Q2
$21K Buy
1,673
+229
+16% +$3.06K ﹤0.01% 3474
2017
Q1
$19K Buy
1,444
+382
+36% +$4.83K ﹤0.01% 3390
2016
Q4
$10K Sell
1,062
-2,000
-65% -$21.9K ﹤0.01% 3620
2016
Q3
$37K Sell
3,062
-1
-0% -$10 ﹤0.01% 2751
2016
Q2
$26K Buy
+3,063
New +$30.2K ﹤0.01% 2885

Other funds holding HALO

Advisor Group's HALO Position: Q4 2019 in Review

Advisor Group reduced its Halozyme (HALO) stake by 3.6% in Q4 2019, selling an estimated $2.35K and leaving 3,672 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #3235.

Advisor Group first reported a position in HALO in Q2 2016 and has held it in 15 quarters since. The position peaked at $82K in Q3 2018. 224 funds tracked by Wall St. Rank hold HALO as of Q4 2019.

  • Advisor Group held 3,672 shares of Halozyme worth $65K as of Q4 2019.
  • Advisor Group sold 136 Halozyme shares in Q4 2019, an estimated $2.35K.
  • Halozyme made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3235 holding.
  • Advisor Group first reported a position in Halozyme in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Halozyme position peaked at $82K in Q3 2018.
  • 224 funds tracked by Wall St. Rank held Halozyme as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.